Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile

EDUARDO MUÑOZ BLANCO2026-01-292026-01-29201610.1016/j.phrs.2016.03.0212-s2.0-84962463401https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/26996PharmacologyBiological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profileresearch article